Clinical Trial

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

Name: Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma — clinical trial record (NCT05700149)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

International retrospective observational cohort study aimed to describe a molecular classification for NMZL.

Protocol Amendment History 1 change

notable Trial sites expanded: 36 -> 50 locations 2026-06-23

Trial Details

NCT Number	NCT05700149
Lead Sponsor	International Extranodal Lymphoma Study Group (IELSG)
Conditions	Nodal Marginal Zone Lymphoma
Enrollment	300 participants
Start Date	2024-04-11
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-22